Neurotechnology Startup Rythm Raises $22 Million
June 16, 2017
1:03 pm
Rythm announced the close of $22 million in financing. Three investors participated in the round, including MAIF Avenir.
Rythm is a neurotechnology company building consumer technology that stimulates the brain to enhance human potential. The company’s first product, Dreem, is a wearable device that syncs with people’s brain activity and stimulates sound to enhance the quality of their sleep.
The company revealed that it will use the proceeds for its product launch.